The study involved four major activities in estimating the current size of the breast reconstruction market. Exhaustive secondary research was conducted to collect information on the market and its different sub segments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub segments
How the market Growth Impact in terms of revenue?
The Global Breast Reconstruction Market size is projected to reach USD 603 million by 2025, at a CAGR of 7.0% during the forecast period.
Breast Reconstruction Market, Growth Factor Analysis:
· Rising incidence of breast cancer
· Increasing awareness
· Reimbursements for breast reconstruction
· Development of 3D-printed implants
Speak to Our Research Analyst, to resolve your Queries:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=186501593
Breast implants accounted for the largest share of the market
Based on the product, the breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2019.
The immediate procedures segment accounted for the largest market share in 2019.
Based on the procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. The immediate procedures segment accounted for the largest market share in 2019. This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness.
Recent Developments
· In 2019, Polytech Health & Aesthetics received US FDA approval for its textured breast implants (macrotextured and polyurethane-coated implants)
· In 2018, J&J launched CPX4 breast tissue expander
· In 2018, Polytech Health & Aesthetics merged with G&G Biotechnology
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593
By region, the breast reconstruction market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. This is attributed to factors such as the rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products
The prominent players operating in the global breast reconstruction market are Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), Polytech Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (Costa Rica), and Silimed (Brazil).
Major Growth Boosting Factors: The rising incidence of breast cancer and the availability of reimbursement for breast reconstruction are major driving factors for the market.
Moreover, the development of 3D-printed breast implants is expected to offer significant growth opportunities to market players in the coming years.Revenue Growth Opportunities: The Global Breast Reconstruction Market size is expected to grow from $603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0%Recent Developments:In 2019, Polytech Health & Aesthetics received US FDA approval for its textured breast implants (macrotextured and polyurethane-coated implants)In 2018, J launched CPX4 breast tissue expanderIn 2018, Polytech Health & Aesthetics merged with G BiotechnologyMarket Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the breast reconstruction market.
The research methodology used to estimate the market size includes the following:The key players in the industry and markets have been identified through extensive secondary research.The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186501593Based on product,Segmented into breast implants, tissue expanders, and acellular dermal matrix.
The breast implants segment accounted for the largest market share in 2019.Based on the procedure,The breast reconstruction market is segmented into immediate, delayed, and revision procedures.
The immediate procedures segment accounted for the largest market share in 2019.
This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness.Based on type,Segmented into unilateral and bilateral.
Healthcare Contract Research Organization Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2019-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the Healthcare Contract Research Organization include ICON Plc, Syneos Health, Covance, Charles River Laboratories (CRL), IQVIA, Covance, PAREXEL International Corporation, Medidata Solutions, GVK Biosciences Private Limited, Pharmaceutical Product Development, LLC (PPD), and Pharmaron..
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Healthcare Contract Research Organization Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/healthcare-contract-research-organization-market/download-sampleMarket SegmentationThe broad Healthcare Contract Research Organization has been sub-grouped into the Type, Service and Region.
The report studies these subsets with respect to the geographical segmentation.
The strategists can gain a detailed insight and devise appropriate strategies to target specific market.
Healthcare Contract Research Outsourcing Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2019-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the Healthcare Contract Research Outsourcing include Albany Molecular Research, Inc., Covance Clinical Biotech, IQVIA Inc, PAREXEL International Corp, Pharmaron, Syneos Health, PRA Health Sciences, Inc., WuXi AppTec, Charles River Laboratories International, Inc, Olon Ricerca Bioscience, Sygnature Discovery Limited, Laboratory Corporation of America® Holdings, ICON plc, Jubilant Biosys Ltd, SynteractHCR, and Pharmaceutical Product Development, LLC..
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Healthcare Contract Research Outsourcing Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/healthcare-contract-research-outsourcing-market/download-sampleMarket SegmentationThe broad Healthcare Contract Research Outsourcing has been sub-grouped into the Service, Therapeutic Area and Region.
The report studies these subsets with respect to the geographical segmentation.
The strategists can gain a detailed insight and devise appropriate strategies to target specific market.
